OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
6509$39.9058

Taiwan Hopax Chems. MFG. Co Ltd

Specialty ChemicalsVerified

Capital Structure and Liquidity The company maintains a market price of 39.9 TWD per share, with a market capitalization of 7.84 billion TWD. Its price-to-book ratio is 1.49, and the price-to-tangible-book ratio is also 1.49, indicating a moderate premium over book value. The enterprise value to EBITDA ratio is 10.21, and the enterprise value to revenue ratio is 1.70, suggesting a relatively balanced valuation. The company has 903.75 million TWD in cash and equivalents, but its net cash position is negative after subtracting total debt, which is a key liquidity flag. ### Profitability and Returns The company's return on equity (ROE) is 10.81%, and its return on assets (ROA) is 7.21%, both of which are strong indicators of profitability. The gross profit margin is 32.34% (1.58 billion TWD gross profit on 4.88 billion TWD revenue), and the operating margin is 16.68% (813.32 million TWD operating income on 4.88 billion TWD revenue). These metrics suggest the company is efficiently managing its costs and generating solid returns on its assets and equity. ### Segments and Geographic Exposure The company operates in multiple product lines, including specialty chemicals, fine chemicals, and office stationery products. Its geographic exposure spans Taiwan, the rest of Asia, Europe, the Americas, and other markets. However, the input data does not provide specific revenue concentration by segment or region, so it is not possible to assess the degree of concentration risk in detail. ### Growth Trajectory The company's most recent actual revenue was 3.46 billion TWD, which is lower than the reported revenue of 4.88 billion TWD. This suggests a potential discrepancy or a recent period of lower performance. The outlook for the current fiscal year and the next fiscal year is not provided in the input data, so it is not possible to assess the growth trajectory in detail. ### Risk Factors The company faces a medium liquidity risk, as indicated by the negative net cash position after subtracting total debt. The dilution risk is assessed as low, and there are no specific dilution sources or expected timeframes provided in the input data. The company's debt-to-equity ratio is 0.26, indicating a relatively conservative capital structure. ### Recent Events The input data does not include recent filings, transcripts, or other events that could impact the company's operations or financial performance. Therefore, it is not possible to assess the impact of recent events on the company.

30-day price · 6509+4.75 (+10.7%)
Low$39.70High$50.50Close$49.15As of21 May, 00:00 UTC
Profile
CompanyTaiwan Hopax Chems. MFG. Co Ltd
Ticker6509.TWO
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustrySpecialty Chemicals
AI analysis

Business. Taiwan Hopax Chems. MFG. Co Ltd is a manufacturer and distributor of chemical products, including specialty chemicals for papermaking, water treatment, and image display, fine chemicals for biological and industrial applications, and office stationery products.

Classification. The company is classified under the Basic Materials economic sector, Chemicals business sector, and Specialty Chemicals industry with a confidence level of 0.92.

### Capital Structure and Liquidity The company maintains a market price of 39.9 TWD per share, with a market capitalization of 7.84 billion TWD. Its price-to-book ratio is 1.49, and the price-to-tangible-book ratio is also 1.49, indicating a moderate premium over book value. The enterprise value to EBITDA ratio is 10.21, and the enterprise value to revenue ratio is 1.70, suggesting a relatively balanced valuation. The company has 903.75 million TWD in cash and equivalents, but its net cash position is negative after subtracting total debt, which is a key liquidity flag. ### Profitability and Returns The company's return on equity (ROE) is 10.81%, and its return on assets (ROA) is 7.21%, both of which are strong indicators of profitability. The gross profit margin is 32.34% (1.58 billion TWD gross profit on 4.88 billion TWD revenue), and the operating margin is 16.68% (813.32 million TWD operating income on 4.88 billion TWD revenue). These metrics suggest the company is efficiently managing its costs and generating solid returns on its assets and equity. ### Segments and Geographic Exposure The company operates in multiple product lines, including specialty chemicals, fine chemicals, and office stationery products. Its geographic exposure spans Taiwan, the rest of Asia, Europe, the Americas, and other markets. However, the input data does not provide specific revenue concentration by segment or region, so it is not possible to assess the degree of concentration risk in detail. ### Growth Trajectory The company's most recent actual revenue was 3.46 billion TWD, which is lower than the reported revenue of 4.88 billion TWD. This suggests a potential discrepancy or a recent period of lower performance. The outlook for the current fiscal year and the next fiscal year is not provided in the input data, so it is not possible to assess the growth trajectory in detail. ### Risk Factors The company faces a medium liquidity risk, as indicated by the negative net cash position after subtracting total debt. The dilution risk is assessed as low, and there are no specific dilution sources or expected timeframes provided in the input data. The company's debt-to-equity ratio is 0.26, indicating a relatively conservative capital structure. ### Recent Events The input data does not include recent filings, transcripts, or other events that could impact the company's operations or financial performance. Therefore, it is not possible to assess the impact of recent events on the company.
Key takeaways
  • The company has a strong return on equity (10.81%) and return on assets (7.21%), indicating solid profitability.
  • The price-to-book and price-to-tangible-book ratios are both 1.49, suggesting a moderate premium over book value.
  • The enterprise value to EBITDA ratio is 10.21, and the enterprise value to revenue ratio is 1.70, indicating a balanced valuation.
  • The company has a negative net cash position after subtracting total debt, which is a key liquidity flag.
  • The company operates in multiple product lines and geographic markets, but the input data does not provide specific revenue concentration details.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyTWD
Revenue$4.88B
Gross profit$1.58B
Operating income$813.3M
Net income$567.4M
R&D
SG&A
D&A
SBC
Operating cash flow$1.23B
CapEx-$405.2M
Free cash flow$197.1M
Total assets$7.87B
Total liabilities$2.63B
Total equity$5.25B
Cash & equivalents$903.7M
Long-term debt$1.37B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price$39.90
Market cap$7.84B
Enterprise value$8.30B
P/E13.8
Reported non-GAAP P/E
EV/Revenue1.7
EV/Op income10.2
EV/OCF6.8
P/B1.5
P/Tangible book1.5
Tangible book$5.25B
Net cash-$461.4M
Current ratio2.2
Debt/Equity0.3
ROA7.2%
ROE10.8%
Cash conversion2.2%
CapEx/Revenue-8.3%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric6509Activity
Op margin16.7%0.4% medp25 -8.0% · p75 16.0%top quartile
Net margin11.6%2.3% medp25 -11.6% · p75 11.8%above median
Gross margin32.3%20.8% medp25 14.9% · p75 24.0%top quartile
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-8.3%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity26.0%59.0% medp25 54.9% · p75 72.9%bottom quartile
Observations
IR observations
Last actual revenue3,459,556,000 TWD
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-04 17:58 UTC#2e547792
Market quoteclose TWD 39.90 · shares 0.20B diluted
no public URL
2026-05-04 17:58 UTC#8ce26a9f
Source: analysis-pipeline (hybrid)Generated: 2026-05-04 18:00 UTCJob: 9e78a2b2